email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
3091 - 3105
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
CFDA Plans to Double Drug Review Staff: From 800 to 1,600
$5.00
Available
WuXi AppTec Forms Clinical Testing JV with the Mayo Clinic
$5.00
Available
Ping An Signs Strategic Oncology Partnership MOU with Varian
$5.00
Available
Shanghai Fosun Forms $50 Million US JV -- With Itself
$5.00
Available
Fosun Pays $18 Million for China Rights to Novel Parkinson's Disease Drug
$5.00
Available
Aslan Says New CFDA Rules Shave One Year Off Development Time for Lead Drug
$5.00
Available
3SBio Approved to Market Once-Weekly Type 2 Diabetes Treatment in China
$5.00
Available
Biostage Raises $4.2 Million from China Investor for Bioengineered Organs
$5.00
Available
Sinobioway and F1 Oncology to Build Shenzhen CAR-T Manufacturing Facility
$5.00
Available
Shenzhen's HEC Pharm Invests in US Novel Imaging Contrast Company
$5.00
Available
CFDA Accepts Ascentage's IND Filing for Lead Drug in Hepatitis B
$5.00
Available
Ally Bridge and LifeTech Scientific Join to Invest in MedTech Companies
$5.00
Available
Simcere Acquires China Rights to Three Bi-Specific Immunoncology Drugs
$5.00
Available
Lepu Medical Pays $23.3 Million for 13% Stake in Australia's Viralytics
$5.00
Available
BeiGene to Generate New mAbs Using Harbour BioMed's Mouse Platform
$5.00
Available